| Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/β-catenin signaling CP Prasad, G Rath, S Mathur, D Bhatnagar, R Ralhan Chemico-biological interactions 181 (2), 263-271, 2009 | 190 | 2009 |
| Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients S Mirza, G Sharma, CP Prasad, R Parshad, A Srivastava, SD Gupta, ... Life sciences 81 (4), 280-287, 2007 | 155 | 2007 |
| Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients G Sharma, S Mirza, CP Prasad, A Srivastava, SD Gupta, R Ralhan Life sciences 80 (20), 1873-1881, 2007 | 155 | 2007 |
| Expression analysis of E-cadherin, Slug and GSK3β in invasive ductal carcinoma of breast CP Prasad, G Rath, S Mathur, D Bhatnagar, R Parshad, R Ralhan BMC cancer 9, 1-10, 2009 | 151 | 2009 |
| Epigenetic alterations of CDH1 and APC genes: Relationship with activation of Wnt/β-catenin Pathway in invasive ductal carcinoma of breast CP Prasad, S Mirza, G Sharma, R Prashad, S DattaGupta, G Rath, ... Life sciences 83 (9-10), 318-325, 2008 | 130 | 2008 |
| Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between β-catenin, disheveled and cyclin D1 expression CP Prasad, SD Gupta, G Rath, R Ralhan Oncology 73 (1-2), 112-117, 2008 | 113 | 2008 |
| Environmental and occupational determinants of lung cancer A Shankar, A Dubey, D Saini, M Singh, CP Prasad, S Roy, SJ Bharati, ... Translational lung cancer research 8 (Suppl 1), S31, 2019 | 111 | 2019 |
| Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward A Shankar, D Saini, A Dubey, S Roy, SJ Bharati, N Singh, M Khanna, ... Translational lung cancer research 8 (Suppl 1), S106, 2019 | 85 | 2019 |
| Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression R Linnskog, G Jönsson, L Axelsson, CP Prasad, T Andersson Molecular oncology 8 (8), 1365-1378, 2014 | 70 | 2014 |
| Role of complementary and alternative medicine in prevention and treatment of COVID-19: an overhyped hope A Shankar, A Dubey, D Saini, CP Prasad Chinese journal of integrative medicine 26 (8), 565, 2020 | 65 | 2020 |
| Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells LM Mehdawi, CP Prasad, R Ehrnström, T Andersson, A Sjölander Molecular oncology 10 (9), 1415-1429, 2016 | 65 | 2016 |
| Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model G Canesin, S Evans-Axelsson, R Hellsten, A Krzyzanowska, CP Prasad, ... PLoS One 12 (9), e0184418, 2017 | 64 | 2017 |
| Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer SAR Bagadi, CP Prasad, A Srivastava, R Prashad, SD Gupta, R Ralhan Breast cancer research and treatment 104, 277-286, 2007 | 64 | 2007 |
| WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition CP Prasad, SK Chaurasiya, W Guilmain, T Andersson Journal of Experimental & Clinical Cancer Research 35, 1-15, 2016 | 62 | 2016 |
| WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells CP Prasad, SK Chaurasiya, L Axelsson, T Andersson Molecular oncology 7 (5), 870-883, 2013 | 61 | 2013 |
| Cancer research in India: Challenges & opportunities M Singh, CP Prasad, TD Singh, L Kumar Indian Journal of Medical Research 148 (4), 362-365, 2018 | 59 | 2018 |
| WNT5A as a therapeutic target in breast cancer CP Prasad, M Manchanda, P Mohapatra, T Andersson Cancer and Metastasis Reviews 37, 767-778, 2018 | 55 | 2018 |
| Cytokine‐and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy AA Bhat, S Nisar, M Singh, B Ashraf, T Masoodi, CP Prasad, A Sharma, ... Cancer Communications 42 (8), 689-715, 2022 | 51 | 2022 |
| Clinical significance of promoter hypermethylation of RASSF1A, RARβ2, BRCA1 and HOXA5 in breast cancers of Indian patients SAR Bagadi, CP Prasad, J Kaur, A Srivastava, R Prashad, SD Gupta, ... Life sciences 82 (25-26), 1288-1292, 2008 | 43 | 2008 |
| Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer SM Umar, A Kashyap, S Kahol, S Mathur, A Gogia, SVS Deo, CP Prasad Experimental Cell Research, 112282, 2020 | 36 | 2020 |
